PLATELET GLYCOPROTEIN IIB/IIIA MONOCLONAL-ANTIBODY (C7E3) REDUCES DISTAL EMBOLIZATION DURING PERCUTANEOUS INTERVENTION OF SAPHENOUS-VEIN GRAFTS

被引：0
|
作者：
CHALLAPALLI, RM [1 ]
EISENBERG, MJ [1 ]
SIGMON, K [1 ]
LEMBERGER, J [1 ]
机构：
[1] CLEVELAND CLIN,CLEVELAND,OH 44106
来源：
CIRCULATION | 1995年 / 92卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2908 / 2908
页数：1
相关论文
共 50 条
  • [41] PROLONGED BLEEDING TIMES DO NOT PREDICT HEMORRHAGIC EVENTS IN PATIENTS RECEIVING THE 7E3 GLYCOPROTEIN-IIB/IIIA PLATELET ANTIBODY
    BERNARDI, MM
    CALIFF, RM
    KLEIMAN, N
    ELLIS, SG
    TOPOL, EJ
    CIRCULATION, 1992, 86 (04) : 260 - 260
  • [42] LACK OF USEFULNESS OF PROLONGED BLEEDING TIMES IN PREDICTING HEMORRHAGIC EVENTS IN PATIENTS RECEIVING THE 7E3 GLYCOPROTEIN IIB/IIIA PLATELET ANTIBODY
    BERNARDI, MM
    CALIFF, RM
    KLEIMAN, N
    ELLIS, SG
    TOPOL, EJ
    AMERICAN JOURNAL OF CARDIOLOGY, 1993, 72 (15): : 1121 - 1125
  • [43] Immunolocalization of blocked and unblocked GP IIb-IIIa complexes in platelets during antithrombotic therapy with c7E3 Fab (ReoPro, abciximab)
    Nurden, A
    Poujol, C
    DurrieuJais, C
    Besse, P
    Jordan, R
    Wagner, C
    Nurden, P
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 184 - 184
  • [44] INHIBITION OF PLATELET GPIIB/IIIA RECEPTOR WITH MONOCLONAL-ANTIBODY [7E3-F(AB')2] PREVENTS ARTERIAL, BUT NOT VENOUS RETHROMBOSIS
    SUDO, Y
    LUCCHESI, BR
    CIRCULATION, 1994, 90 (04) : 181 - 181
  • [45] A MURINE MONOCLONAL-ANTIBODY CONTAINS AN RGD-SEQUENCE IN THE HEAVY-CHAIN CDR3 (H3) INVOLVED IN THE INHIBITION OF PLATELET GLYCOPROTEIN-IIB/IIIA FUNCTION
    DECKMYN, H
    STANSSENS, P
    HOET, B
    DECLERCK, PJ
    LAUWEREYS, M
    GANSEMANS, Y
    TORNAI, I
    VERMYLEN, J
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1002 - 1002
  • [46] Benefit of bolus-only platelet glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: Insights from the very early outcomes in the Evaluation of 7E3 for the Prevention of Ischemic Complications (EPIC) trial
    Marmur, Jonathan D.
    Mitre, Cristina A.
    Barnathan, Elliot
    Cavusoglu, Erdal
    AMERICAN HEART JOURNAL, 2006, 152 (05) : 876 - 881
  • [47] 7E3 monoclonal antibody directed against the platelet glycoprotein IIb/IIIa cross-reacts with the leukocyte integrin Mac-1 and blocks adhesion to fibrinogen and ICAM-1
    Simon, DI
    Xu, H
    Ortlepp, S
    Rogers, C
    Rao, NK
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (03) : 528 - 535
  • [48] PHARMACODYNAMIC STUDY OF F(AB')2 FRAGMENTS OF MURINE MONOCLONAL ANTIBODY-7E3 DIRECTED AGAINST HUMAN PLATELET GLYCOPROTEIN-IIB/IIIA IN PATIENTS WITH UNSTABLE ANGINA-PECTORIS
    GOLD, HK
    GIMPLE, LW
    YASUDA, T
    LEINBACH, RC
    WERNER, W
    HOLT, R
    JORDAN, R
    BERGER, H
    COLLEN, D
    COLLER, BS
    JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (02): : 651 - 659
  • [49] Marked enhancement of clinical efficacy of platelet GP IIb/IIIa blockade with c7E3 fab (Abciximab) linked to reduction in bleeding complications: Outcome in the EPILOG and EPIC trials
    Lincoff, AM
    Tcheng, JE
    Miller, DP
    Booth, JE
    Montague, EA
    Topol, EJ
    CIRCULATION, 1996, 94 (08) : 2185 - 2185
  • [50] Dissociation between the anti-aggregatory & anti-secretory effects of platelet integrin alpha(IIb)beta(3) (GPIIb/IIIa) antagonists, c7E3 and DMP728
    Tsao, PW
    Forsythe, MS
    Mousa, SA
    THROMBOSIS RESEARCH, 1997, 88 (02) : 137 - 146
12345